Tonix Pharmaceuticals Holding Corp. (TNXP) stock is currently valued at $1.77. During the last session, the stock experienced a remarkable rise, reaching $2.05 after opening at $1.90. The stock briefly dropped to $1.77 before ultimately closing at $1.88.
Tonix Pharmaceuticals Holding Corp.’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $29.94 on 06/01/22 and a low of $1.76 for the same time frame on 05/11/23.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
52-week price history of TNXP Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Tonix Pharmaceuticals Holding Corp.’s current trading price is -94.09% away from its 52-week high, while its distance from the 52-week low is 0.75%. The stock’s price range during this period has spanned from $1.76 to $29.94. In the Healthcare sector, the Tonix Pharmaceuticals Holding Corp.’s shares surpassed a trading volume of approximately 0.69 million for the day, which was noticeably higher compared to the average daily volume of 9.0.2 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Tonix Pharmaceuticals Holding Corp. (TNXP) has experienced a quarterly decline of -60.87% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 18.30M and boasts a workforce of 117 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 4.3868, with a change in price of -0.3125. Similarly, Tonix Pharmaceuticals Holding Corp. recorded 446,398 in trading volume during the last 100 days, posting a change of -15.01%.
Examining TNXP’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for TNXP stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
TNXP Stock Stochastic Average
Today, Tonix Pharmaceuticals Holding Corp.’s raw stochastic average for the past 50 days stands at 0.48%, indicating a decline from the raw stochastic average of the last 20 days, which was 0.85%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 4.71% and 6.06% respectively.
TNXP Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Until today this year the stock’s price performance recorded a decrease of -27.35%. However, over the last six months, the performance has been stronger by -32.91%. The price of TNXP decreased -39.87% over the last 30 days. And in the last five days, it has fallen by -7.33%.
